NIH PAR · NIDA · R34
PAR-25-100: Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Notice of Funding Opportunity (NOFO) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This NOFO provides resources for assessing the feasibility,…
- NOFO number
- PAR-25-100
- Type
- PAR
- Activity code
- R34
- Primary institute
- NIDA · National Institute on Drug Abuse
- Clinical trials
- Optional
- Posted
- Dec 6, 2024
- Opens
- Jan 16, 2025
- Expires
- May 8, 2027
PAR-25-100 due dates
2 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
Projects funded under PAR-25-100
NIH RePORTER lists 4 projects funded under PAR-25-100 in FY2022–FY2026, with $1.5M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
4
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$1.5M
Award dollars under PAR-25-100, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 4 | 4 | $1.5M |
Institutions with the most funding
- University of Southern California$751K · 1 project
- Boston Medical Center$296K · 1 project
- University of California-Irvine$236K · 1 project
- Emory University$211K · 1 project
Funding institutes
- NIDA$1.5M · 4
Activity codes funded
- R344 records
Most recent new awards
- Promoting Housing Stability and Preventing Overdose Deaths Among People Recently Housed: Housing plus Overdose Prevention (HOPE) Navigation (opens NIH RePORTER)
Boston Medical Center · 1R34DA067031-01 · NIDA · Notice Aug 21, 2026
$296KR34
- Mobilizing Recovery Capital to Improve Outcomes for People living with HIV and Methamphetamine Use Disorder (opens NIH RePORTER)
Emory University · 1R34DA066379-01 · NIDA · Notice Aug 13, 2026
$211KR34
- Intelligent chatbot for online support groups to treat tobacco addiction. (opens NIH RePORTER)
University of California-Irvine · 1R34DA061012-01A1 · NIDA · Notice May 28, 2026
$236KR34
- A Brief Mobile Intervention to Address Prenatal Cannabis Use (opens NIH RePORTER)
University of Southern California · 1R34DA063961-01A1 · NIDA · Notice Mar 26, 2026
$751KR34
What its predecessor PA-21-180 funded
PAR-25-100 reissues PA-21-180. Its funding history is the best guide to who wins under this program: 14 projects and $9.4M in FY2022–FY2026.
Projects funded
14
Distinct projects, FY2022–FY2026
New awards
14
Type 1 (new project) award records
NIH funding
$9.4M
Award dollars under PA-21-180, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 3 | 3 | $817K |
| FY2023 | 11 | 8 | $3.4M |
| FY2024 | 11 | 2 | $2.5M |
| FY2025 | 9 | 0 | $2.0M |
| FY2026 | 3 | 1 | $702K |
Institutions with the most funding
- University of Washington$1.4M · 2 projects
- Boston Medical Center$801K · 1 project
- Johns Hopkins University$737K · 1 project
- University of Colorado Denver$727K · 1 project
- Rhode Island Hospital$723K · 1 project
- Baystate Medical Center, Inc.$720K · 1 project
- Ohio University Athens$714K · 1 project
- Trustees of Indiana University$713K · 1 project
Funding institutes
- NIDA$8.8M · 36
- NIAAA$671K · 1
Activity codes funded
- R3437 records
Most recent new awards
- Dronabinol and Epidiolex (Cannabidiol) for Uncontrolled Residual Symptoms of Buprenorphine Initiation (Demure Trial) (opens NIH RePORTER)
Albert Einstein College of Medicine · 1R34DA063987-01 · NIDA · Notice Apr 27, 2026
$252KR34
- Implementing a Low-Threshold Hepatitis C Treatment in a Jail Setting (opens NIH RePORTER)
Rhode Island Hospital · 1R34DA061732-01 · NIDA · Notice Sep 13, 2024
$252KR34
- Developing and Piloting a Supervision Strategy for Substance Use Disorder Treatment Programs (opens NIH RePORTER)
Univ of Arkansas for Med Scis · 1R34DA060419-01 · NIDA · Notice Jul 9, 2024
$228KR34
- Proud to Quit (P2Q): A Person-centered mobile technology intervention for smoking cessation among transgender adults (opens NIH RePORTER)
University of Colorado Denver · 1R34DA058191-01 · NIDA · Notice Sep 22, 2023
$260KR34
- Sustaining recovery for people on opioid agonist treatment with conversational agents (opens NIH RePORTER)
Boston Medical Center · 1R34DA058124-01A1 · NIDA · Notice Sep 20, 2023
$316KR34
- Conversations can save lives: TALKing About Buprenorphine & methadone for Opioid Use Treatment Initiation (TALK ABOUT) (opens NIH RePORTER)
Baystate Medical Center, Inc. · 1R34DA058199-01A1 · NIDA · Notice Sep 18, 2023
$320KR34
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-100. Contact the program officer at the institute that fits your research before applying.
- NIDA · National Institute on Drug Abuse
- none
Related notices
Jun 3, 2025 · NOT-DA-25-039
Notice of Change to PAR-25-100, Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders R34 Clinical Trial Optional)".
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022
Implementation Details for the NIH Data Management and Sharing Policy.
Notices of Special Interest (NOSIs)
NIH has attached 11 NOSIs to PAR-25-100; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Direct costs are limited to 450,000 over the 3-year project period, with no more than 225,000 in direct costs allowed in any single year.
- Project period
- The total project period for an application submitted may not exceed three years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PA-21-180.
Other open NOFOs for R34
- PAR-24-329Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)NIDA · next due Oct 16, 2026
- PAR-25-378Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)NIDA · next due Oct 21, 2026
- PAR-25-358NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)NEI · next due Oct 16, 2026
- PAR-25-284Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)NIMH · next due Oct 16, 2026
- PAR-25-032NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)NHLBI · next due Oct 16, 2026
- PAR-25-159Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)NIAAA · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.